UK markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6900-0.1300 (-3.40%)
At close: 04:00PM EDT
3.6900 0.00 (0.00%)
After hours: 04:07PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.77-0.7-2.96-2.9
Low estimate-0.79-0.85-3.3-3.21
High estimate-0.75-0.47-2.48-2.74
Year ago EPS-0.34-0.4-1.63-2.96
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. EstimateN/AN/AN/A53.01M
Low estimateN/AN/AN/A24.4M
High estimateN/AN/AN/A96.63M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.47-0.48-0.5-0.61
Actual EPS-0.34-0.4-0.47-0.75
Difference0.130.080.03-0.14
Surprise %27.70%16.70%6.00%-23.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.77-0.7-2.96-2.9
7 days ago-0.77-0.7-2.96-2.9
30 days ago-0.68-0.71-2.76-2.92
60 days ago-0.68-0.71-2.76-2.92
90 days ago-0.64-0.66-2.820.1
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A211
Up last 30 daysN/A211
Down last 7 daysN/AN/AN/AN/A
Down last 30 days4233
Growth estimatesAVIRIndustrySector(s)S&P 500
Current qtr.-126.50%N/AN/AN/A
Next qtr.-75.00%N/AN/AN/A
Current year-81.60%N/AN/AN/A
Next year2.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A